Nabis Announces Exclusive Partnership with dosist™ to Distribute All THC Products in California
October 8th, 2020
News, Top News
OAKLAND, Calif., Oct. 7, 2020 /PRNewswire/ — Nabis, California’s fastest growing software-driven cannabis distributor, announced today that the company entered into a definitive agreement with dosist in early 2020 to provide exclusive distribution for their cannabis products in California.
Since launching in 2016, dosist has become a globally recognized brand through its award-winning products, focus on testing and quality, and recognition from companies like Time and Fast Company. As the pioneer of dose-controlled cannabis technology and a leader in quality of life need-state formulations, dosist has consistently established itself as one of the top selling brands in its category in the largest legal US cannabis market (California).
Through this agreement Nabis is the exclusive distributor of dosist’s thc products in California. This includes dosist’s proprietary medical-grade dose pen™ rechargeable system and its newly engineered dose pen™ 100, both available in the brand’s core formulas including bliss, sleep, calm, relief and arouse, as well as three new high potency thc-plus formulas. This will also include distribution of the dose dial™, a delivery device that administers the dosist edible tablet, available in bliss and calm. Each dosist device delivers a precise dose each and every time, ensuring a customer has a consistent and repeatable experience.
“We are incredibly excited to add dosist to our family of Nabis-distributed brands. Needless to say, dosist is one of the most recognizable and reputable cannabis brands in the world. For the past several months, we’ve been working tirelessly to transition their supply chain operations, and I’m delighted to finally share the news with the public,” said Jun S. Lee, President of Nabis. “Nabis shares the modern aesthetics, focus on technology, and the commitment to quality that dosist brings to the industry. We’re delighted and humbled to help dosist further its distribution footprint in California.”
“We are very pleased to partner with Nabis on the distribution of dosist’s rapidly expanding thc portfolio in our home state of California,” said Gunner Winston, CEO of dosist. “Nabis has become a leader in modern technology-based cannabis distribution and services, and they share our commitment to providing retailers with a stable, streamlined approach to delivery and support. We look forward to building our business and footprint with them over the coming years.”
Nabis is a leading technology-driven cannabis distributor based in California, providing a wide range of services for the wholesale cannabis market including warehousing, fulfillment, data analytics, and financial services. Founded in 2017 on a simple mission to modernize the cannabis supply chain, Nabis offers an elegant software and infrastructural solution for cannabis brands to effortlessly solve their distribution.
dosist, based in Los Angeles, California, launched in 2016 and has since become known as a disruptor in the health and wellness industry, named one of Time Magazine’s Best Inventions of 2016, recognized by Fast Company as one of 2018’s Top 10 Most Innovative Companies in the health sector, and designated by LinkedIn as the number two Top Startups 2019: Hottest U.S. Companies To Work For Now. Through its eight targeted formulations: bliss, sleep, calm, relief, arouse, bliss thc-plus, arouse thc-plus and relax thc-plus, dosist provides natural alternatives for some of our most common ailments. Their proprietary medical-grade dose pen™ rechargeable, newly engineered dose pen™ 100 and their dose dial™ (dial available in California only) deliver a precise dose each and every time, ensuring a customer has a consistent and repeatable experience. For more information about dosist and our products visit our website at dosist.com and follow us on Facebook and Instagram.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.